Discover uBriGene's advancements at the Advanced Therapies 2024
November 12, 2024
uBriGene Biosciences is thrilled to announce our participation in The Advanced Therapies Congress, happening on November 12-13, 2024, at the Pennsylvania Convention Center in Philadelphia, USA. As America's premier commercial cell and gene therapy conference, this event is all about tackling the challenges that lie ahead in developing next-generation therapies to improve patient outcomes.
At booth 401, uBriGene will proudly showcase two exciting posters that highlight our innovative contributions to the field:
1. CRISPR Gene Editing Innovations for Cell and Gene Therapy dives into our cutting-edge approach to producing sgRNA using in vitro transcription (IVT) technology. This method not only offers a more scalable and cost-effective alternative to traditional chemical synthesis but also enhances gene editing efficiency when combined with our GMP-grade Cas9 proteins and closed-end linear DNA. We’re excited to share how these advancements can accelerate the development of advanced therapies!
2. Efficient Generation of Integration-Free Induced Pluripotent Stem Cells (iPSCs) via an mRNA Lipid Nanoparticle System presents a groundbreaking mRNA lipid nanoparticle (LNP) system that reprograms skin fibroblasts into integration-free iPSCs. This innovative method is not only safer and simpler than existing techniques but also more cost-effective, making it a promising solution for regenerative medicine and cell therapy applications.
We can’t wait to connect with fellow experts, decision-makers, and innovators at the congress to discuss our latest breakthroughs and ongoing projects. Be sure to stop by booth 401—we’d love to share our journey and explore how we can collaborate to drive the future of advanced therapies together!